Skip to main content
Caplight Logo









Aromyx

Aromyx

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://aromyx.com/

Last Round

Series A

Jul 20, 2021

Total Funding Raised

$16.85M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Aromyx is a biotechnology company that has developed a platform to measure and digitize taste and scent using biological receptors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Business Intelligence, Sensors, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

sensory digitizationelectronic nosee-nosehuman receptor biosensorsensory data analyticsquantitative sensory analysisdigital scent technologyAI for flavor and fragranceproduct reformulationsensory testing servicesflavor and fragrance R&Ddisposable biosensorCPG R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aromyx Comparables

Compare Aromyx with similar companies based on industry and business-model similarity.

Aromyx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ScentifAI, Inc.
80%
Aryballe Technologies
77%
Scentian Bio
77%

Aromyx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 20, 2021
SeedJun 26, 2019
GrantMar 21, 2019
SeedSep 1, 2016

Aromyx Investors

Notable investors and investment history

Aromyx investors
InvestorRounds
Capital Energy QuantumSeries A
Radicle GrowthSeries A, Seed, Grant
Rationalwave Capital PartnersSeed
Ulu VenturesSeries A, Seed
Oriza VenturesSeed
TSV CapitalSeed
Rabo InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 275% MoM, reaching 2.2K.

Aromyx Filings

Explore SEC and related filing metadata, where available.

Aromyx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aromyx's valuation, stock price, and market status.

Is Aromyx a public or private company?

Aromyx is a private company.

What is the current stock price of Aromyx?

Aromyx is a private company with no public stock price. Caplight tracks Aromyx's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Aromyx worth (valuation)?

Valuation information for Aromyx is not publicly available.

Can I buy Aromyx stock?

Aromyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aromyx's last funding round?

Aromyx's most recent funding round was Series A on July 20, 2021.

Who are the main investors in Aromyx?

Key investors in Aromyx include Radicle Growth, Ulu Ventures, Rabo Investments, Sozo Ventures.

Will Aromyx IPO soon?

No public IPO plans have been announced for Aromyx.

How can I track Aromyx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aromyx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMountain View, California
Employee Range3
Year Founded2014
Last FundingJul 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?